Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease

Fig. 1

ASC characterization and inflammatory modulation. a, c Representative dot plots of hemato-endothelial (CD31-34-45) and MSC (CD44-73-90) markers in ASCs. One representative cell isolate is shown. d IFNγ effects on targets reported to be modulated by different inflammatory stimuli. Log2 ratios of iASCs vs ASCs are shown

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512